Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01183962 · ClinicalTrials.gov registry record · NA
Vitamin D and T-Regulatory Cells in Coronary Artery Disease
A NA study, sponsored by Creighton University.
- Terminated
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT01183962: Clinical Trial NA study, sponsored by Creighton University.
NCT01183962 is a NA study that was terminated before completion, run by Creighton University. The registered enrollment target is 50 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01183962, a NA study, was terminated before completion, sponsored by Creighton University.
- TERMINATED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effect of Vitamin D supplementation on cardiovascular disease and certain cells (T-regulatory cells) in the body that play a role in plaque formation in arteries. This study will determine the levels of Vitamin D and T-regulatory cells in subjects with coronary artery disease and if Vitamin D supplementation will affect future events such as heart attach and stroke.
Primary Outcome
We expect significant improvement in the suppressive capacity, with or without increase in the number, of circulating T-regs after vitamin D supplementation. This increase in T-regs function will correlate with improvement in clinical parameters.
Interventions
- DIETARY_SUPPLEMENT Vitamin D
- OTHER No medication
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2010-02 |
| Phase | NA |
Why NCT01183962 stopped before completion
NCT01183962 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 2 interventions - of which Vitamin D is the first listed.
NCT01183962 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01183962 about?
NCT01183962 is a clinical study titled "Vitamin D and T-Regulatory Cells in Coronary Artery Disease". The purpose of this study is to evaluate the effect of Vitamin D supplementation on cardiovascular disease and certain cells (T-regulatory cells) in the body that play a role in plaque formation in arteries. This study will determine the levels of Vitamin D and T-regulatory cells in subjects with co...
What is the current status of trial NCT01183962?
This trial is currently terminated. It is a NA study. The enrollment target is 50 participants. The study started on 2010-02.
What interventions are being tested in trial NCT01183962?
The interventions under investigation include: Vitamin D (DIETARY_SUPPLEMENT), No medication (OTHER).
Who is sponsoring clinical trial NCT01183962?
This trial is sponsored by Creighton University, which has 98 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01183962's enrollment target sits among peer trials
50 1279th of 2000 higher than 622 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia